APA (7th ed.) Citation

M, K., G, K., H, L., JS, S., & HS, K. (2026). Polymeric nanoparticle-mediated GBA1 gene therapy is neuroprotective in a preclinical model of Parkinson's disease. Drug delivery and translational research, 16(3), 894. https://doi.org/10.1007/s13346-025-01944-3

Chicago Style (17th ed.) Citation

M, Kwatra, Kwak G, Li H, Suk JS, and Ko HS. "Polymeric Nanoparticle-mediated GBA1 Gene Therapy Is Neuroprotective in a Preclinical Model of Parkinson's Disease." Drug Delivery and Translational Research 16, no. 3 (2026): 894. https://doi.org/10.1007/s13346-025-01944-3.

MLA (9th ed.) Citation

M, Kwatra, et al. "Polymeric Nanoparticle-mediated GBA1 Gene Therapy Is Neuroprotective in a Preclinical Model of Parkinson's Disease." Drug Delivery and Translational Research, vol. 16, no. 3, 2026, p. 894, https://doi.org/10.1007/s13346-025-01944-3.